Other

April 09, 2008

Marvin D. Shepherd, PhD

Shepherd 2B.jpg
Dr. Marv Shepherd is the Director of the Center for Pharmacoeconomic Studies and Chairman of the Pharmacy Administration Division at the University of Texas at Austin’s College of Pharmacy.  He also serves as the Chairman of the Board of Directors for the Partnership for Safe Medicines. 

Among his many research interests, Dr. Shepherd examines the policies related to drug importation and re-importation—especially from Mexico—the use of drug anti-counterfeiting strategies, and techniques for monitoring prescription drug diversion. His research and expertise on drug importation and drug counterfeiting has been featured on CNN News, NPR Radio: First Edition, Newsweek, Wall Street Journal, Money Magazine, Time Magazine, Prevention Magazine, US News and World Report, New York Times, USAToday, Washington Post, plus many other national newspapers, magazines, and television and radio news broadcasts.

He earned a Bachelor of Science in biology from Michigan Technological University, Bachelor of Science in pharmacy from Ferris State University, Master of Science from the University of Rhode Island, and PhD from Purdue University.

Posted by safemedicines2 at 04:55 PM
November 26, 2007

Bryan A. Liang, MD, PhD, JD

Dr. Bryan A. Liang is Executive Director and E. Donald Shapiro Distinguished Professor of Health Law, Institute of Health Law Studies, California Western School of Law; Co-Director and Adjunct Associate Professor of Anesthesiology, San Diego Center for Patient Safety, University of California San Diego School of Medicine; Adjunct Associate Professor of Public Health, Global Emergency Preparedness and Response Program, San Diego State University; and Adjunct Professor of Aviation, Western Michigan University College of Aviation. He also serves as the Vice President for the Partnership for Safe Medicines. 

Dr. Liang's research and advocacy focus is patient safety and access to care. He has published and spoken widely on the topic of safety and vulnerability of the drug supply, with more than 300 publications and presentations in domestic and international public and private forums. He received his Bachelor of Science from MIT; PhD from the University of Chicago; MD from Columbia University College of Physicians & Surgeons; and JD from Harvard Law School.

Posted by safemedicines at 09:13 AM